Hereditary transthyretin amyloidosis caused by Val142Ile variant in Spain: phenotypic characteristics, geographic distribution and population frequency.

1 September 2024 (14:00 - 14:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Fernando de Frutos Seminario

University Hospital of Bellvitge, Barcelona (Spain)

9 More presentations in this session

Presentation thumbnail

Sustained paradoxical vasodilation and blood pressure lowering in response to sympathetic stimulation as markers of disease severity and poor survival in primary AL amyloidosis.

Doctor K. Stamatelopoulos (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Changes in the diagnostic landscape of transthyretin amyloid cardiomyopathy (ATTR-CM): a comparison of tests ordered and test Intervals in 2020 Q4 and 2023 Q4

Mr P. Collins (London, GB)

Abstract Slides Video

Presentation thumbnail

Frailty and associated outcomes in patients with transthyretin cardiac amyloidosis

Doctor C. Fumagalli (Naples, IT)

Abstract Slides Video

Presentation thumbnail

Cardiac transthyretin amyloidosis in patients with conduction system disease

Doctor J. Pudich (Ostrava, CZ)

Abstract Slides Video

Presentation thumbnail

ATTR cardiac amyloidosis after lumbar spinal stenosis- a prospective cohort study

Doctor P. Eldhagen (Stockholm, SE)

Abstract Slides Video

Access the full session

Session thumbnail

The different faces of cardiac amyloidosis

The Event

Event poster

ESC Congress 2024

1 September 2024 14:00 CET

You may be interested in

Congress Presentation

Comparison of phenotype and prognosis of hereditary Val122Ile and wild type transthyretin cardiomyopathy.

Congress Presentation

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) cardiogenomics: a tertiary centre experience

Congress Session

The evolving landscape of transthyretin amyloidosis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources